These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 6107853

  • 1. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease.
    Klotz U, Maier K, Fischer C, Heinkel K.
    N Engl J Med; 1980 Dec 25; 303(26):1499-502. PubMed ID: 6107853
    [Abstract] [Full Text] [Related]

  • 2. [5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)].
    Maier K, Fischer C, Klotz U, Heinkel K.
    Dtsch Med Wochenschr; 1982 Jul 23; 107(29-30):1131-4. PubMed ID: 6123426
    [Abstract] [Full Text] [Related]

  • 3. [Long-term therapy in ulcerative colitis and Crohn's disease].
    Malchow H.
    Fortschr Med; 1979 Aug 02; 97(29):1253-60. PubMed ID: 457018
    [Abstract] [Full Text] [Related]

  • 4. [Estimations of the serum levels of sulfapyridine on patients treated with sulfasalazin (author's transl)].
    Eitner K, Hippius M, Reinicke C.
    Dtsch Z Verdau Stoffwechselkr; 1982 Aug 02; 42(1):14-9. PubMed ID: 6122556
    [Abstract] [Full Text] [Related]

  • 5. [Successful acute treatment of chronic inflammatory intestinal diseases with oral 5-aminosalicylic acid].
    Maier K, Frühmorgen P, Bode JC, Heller T, von Gaisberg U, Klotz U.
    Dtsch Med Wochenschr; 1985 Mar 08; 110(10):363-8. PubMed ID: 2857633
    [Abstract] [Full Text] [Related]

  • 6. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
    Habal FM, Greenberg GR.
    Am J Gastroenterol; 1988 Jan 08; 83(1):15-9. PubMed ID: 2892391
    [Abstract] [Full Text] [Related]

  • 7. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
    Segars LW, Gales BJ.
    Clin Pharm; 1992 Jun 08; 11(6):514-28. PubMed ID: 1600685
    [Abstract] [Full Text] [Related]

  • 8. Sulfasalazine and new analogues.
    Friedman G.
    Am J Gastroenterol; 1986 Feb 08; 81(2):141-4. PubMed ID: 2868653
    [No Abstract] [Full Text] [Related]

  • 9. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
    Feurle GE, Helmstädter V.
    Dtsch Med Wochenschr; 1986 May 02; 111(18):721-2. PubMed ID: 2870908
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sulfasalazine and 5-ASA compounds.
    Allgayer H.
    Gastroenterol Clin North Am; 1992 Sep 02; 21(3):643-58. PubMed ID: 1355468
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Current therapeutic possibilities in chronic inflammatory intestinal diseases].
    Schölmerich J.
    Praxis (Bern 1994); 1995 Jan 10; 84(2):29-33. PubMed ID: 7839043
    [Abstract] [Full Text] [Related]

  • 15. Chemistry, pharmacology, pharmacokinetics, and clinical applications of mesalamine for the treatment of inflammatory bowel disease.
    Small RE, Schraa CC.
    Pharmacotherapy; 1994 Jan 10; 14(4):385-98. PubMed ID: 7937276
    [Abstract] [Full Text] [Related]

  • 16. Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission.
    Eliakim R, Wengrower D, Ligumsky M, Rachmilewitz D.
    Isr J Med Sci; 1990 Jan 10; 26(1):47-9. PubMed ID: 1968895
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.